NEW YORK (GenomeWeb News) – Japanese diagnostic firm Sysmex will buy a 34 percent equity stake in bioMérieux’s Japanese subsidiary as part of an agreement to form a joint venture that will market bioMérieux’s in vitro diagnostics products in Japan.
 
The joint venture, which will hold the name Sysmex bioMérieux, will market bioMérieux’s entire product line in Japan beginning April 1. Prior to the agreement, bioMérieux’s Japanese operations were managed by its wholly owned subsidiary bioMérieux Japan.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.